Assessment of Midodrine in the Prevention of Vasovagal Syncope (POST 4)

米多君预防血管迷走性晕厥的评估（POST 4）

• 批准号: 223187
• 负责人: Sheldon Robert S
• 金额: $ 41.55万
• 依托单位: University of Calgary
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2011
• 资助国家: 加拿大
• 起止时间: 2011-03-01 至 2016-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=223187&lang=en
• 关键词: Hypotension; Midodrine; Randomized Clinical Trial; Syncope; Vasovagal

Fainting affects about 50% of Canadians, is the cause of 1-2% of emergency room visits, and probably causes $250 million in health care spending each year. Frequent fainting causes a poor quality of life, and problems at work, at home, and while driving.

昏厥影响了大约50%的加拿大人，是1-2%急诊室就诊的原因，每年可能造成2.5亿美元的医疗支出。经常晕厥会导致生活质量下降，在工作、家庭和开车时也会出现问题。